Pete Sabrofoulos
Analyst
Cantor Fitzgerald
Equibles does not estimate personal net worth.
About Pete Sabrofoulos
Pete Sabrofoulos is recorded as Analyst at Cantor Fitzgerald. Pete Sabrofoulos has spoken on 1 earnings call across 1 company, most recently for Harmony Biosciences Holdings, Inc. on May 7, 2026. The companies whose calls Pete Sabrofoulos spoke on are classified in the Healthcare sector.
Pete Sabrofoulos on recent calls
“You know, can you touch on EPX 100 for Dravet? The clinical data disclosed at AAN. Can you comment on baseline seizure rates and baseline anti-seizure med use? Sort of how do they compare to the real-world patients and patients enrolled in other Dravet clinical trials?”
Affiliation history
-
Cantor Fitzgerald
Analyst
Transcript header (unverified)
Current